The role of ventricular ectopic beats (VEBs) in identifying patients who die of cardiac cause in the posthospital phase of myocardial infarction was evaluated in 940 patients who survived an acute coronary event. Six-hour Holter ECG recordings were obtained before hospital discharge, and VEBs were classified as complex (bigeminal, multiform, repetitive or R on T), simple (one or more VEBs that did not have complex patterns), or not present. Patients were followed 1-60 months (average 36 months) and cardiac mortality was categorized as sudden (< I hour) or nonsudden (> I hour) among 98 witnessed cardiac deaths. Complex VEBs were associated with a significantly increased cardiac death rate, but did not discriminate between sudden and nonsudden death. Simple VEBs were associated with a 3-year cardiac mortality rate intermediate between those with complex and those with no VEBs. The relationship between complex VEBs and cardiac mortality was independent of 10 relevant clinical variables.
NUMEROUS INVESTIGATORS have found that certain ventricular ectopic beat (VEB) characteristics recorded in patients after acute myocardial infarction are harbingers of subsequent cardiac death. [1] [2] [3] [4] [5] Epidemiologic studies from the Tecumseh6 and Coronary Drug Project7 programs have revealed that VEBs recorded on a 12-lead ECG are associated with an increased risk of sudden death during a variable [2] [3] [4] [5] year follow-up. Recently, Ruberman et al. 8 assessed the influence of VEBs on mortality in 1739 men monitored for 1 hour within the first year after myocardial infarction. Using survivorship analysis, they found that complex VEBs (R on T, runs of two or more, multiform or bigeminal beats), but not simple VEBs, were associated with a risk of sudden death three times that of men who did not have complex VEBs. Furthermore, complex VEBs made an independent contribution to the mortality risk. The Ruberman findings have profound implications on antiarrhythmic intervention trials to reduce cardiac death in general, and sudden cardiac death in particular, in the posthospital phase of myocardial infarction.
The present study is an outgrowth of a prospective postcoronary investigation initiated in Rochester, New York in 1972 to better understand the factors associated with cardiac death in the posthospital phase of myocardial infarction. The purposes of this investigation are: 1) to apply the Ruberman VEB criteria to the Rochester population to validate or refute their findings; and 2) to explore the role of both simple and complex VEBs as they relate to sudden and nonsudden cardiac death throughout both the early and late posthospital phases of myocardial infarction.
Methods Population
The study population consisted of 978 Monroe County residents, 798 men and 180 women younger than 66 years of age, who entered coronary care units in two Rochester community hospitals between January 1, 1973 and December 31, 1976, with either a definite or probable acute myocardial infarction (AMI) and who survived hospitalization. Definite myocardial infarction was substantiated by the presence of any two of the following: typical coronarytype chest pain, serial acute myocardial enzyme changes, or electrocardiographic documentation (an evolving Q wave abnormality with acute ST-and Twave changes). Patients with probable myocardial infarction had typical coronary-type chest pain with minor enzyme changes and/or ECG-documented acute ST-and T-wave changes. Both the patient and the private physician had to give informed consent before the patient was enrolled in the study.
Data Acquisition
Nurse investigators interviewed the patients and reviewed the patients' hospital charts during the last week of hospitalization. The patients' medical history before entry and their clinical course during the CCU and subsequent hospitalization were recorded on prospectively designed forms as previously described. 9 Clinical variables used in this study included: 1) demographic data; 2) historical comorbidity, such as prior myocardial infarction, hypertension, angina pectoris and diabetes mellitus; 3) severity of the acute coronary event in terms of left ventricular dysfunction 998 (LVD) as manifest by pulmonary congestion or congestive heart failure* in the coronary care unit; and 4) myocardial infarct location as determined by Minnesota classification'0 of a 12-lead ECG categorized into anterior (Q/QS = 1.11-1.12), posterior (Q/QS = 1.14), and other (non-Q/QS abnormality) locations. One 6-hour Holter-type ECG tape recording was obtained for each patient some time during the last 3 days of hospitalization before discharge. These recordings were analyzed using a rapid 60:1 scan technique for VEBs as previously reported.9 VEBs were categorized by: 1) number of VEBs/hour; and 2) patterns in terms of VEBs that were bigeminal, multiform, repetitive (two or more consecutive VEBs in a row), or early cycle with R-on-T phenomenon (RR'/QT < 1.00). The VEBs were subsequently subdivided into: 1) complex patternsbigeminal, multiform, repetitive, or early cycle VEBs (essentially the same as the Ruberman criteria;8 and 2) simple patternsone or more VEBs without complex patterns.
Of the 978 patients in the study population, 38 patients had the following missing values: 28 had technically unsatisfactory predischarge Holter recordings; nine had missing data regarding roentgenographic evidence of interstitial or alveolar edema; and one had missing data for prior myocardial infarction. Patients with missing values were excluded from analysis, and the net study population was 940 patients.
Mortality
The enrolled patients were given sequential 4-month follow-up appointments during the study from January 1, 1973 through December 31, 1977. All patients who died before January 1, 1978 were identified. The study population was exposed to the risk of dying from a minimum of 12 months (those who entered in December 1976) to a maximum of 60 months (those who entered in January 1973). When a nonsurvivor was identified, information was gathered from immediate family members, the personal physician, and witnesses of the terminal event.
This information was evaluated by a mortality review committee, and a cause of death was assigned to each nonsurvivor as previously described.'1 Patients who died from cardiac and noncardiac causes were identified. Sudden cardiac death was defined as death that occurred within 1 hour of the onset of acute cardiac symptoms. During the period from January 1, 1973 through December 31, 1977, 134 of the 940 patients died, and 115 of these deaths were from cardiac causes. Of the 115 cardiac deaths, 55 were sudden, 43 were nonsudden and 17 were unwitnessed.
Statistical Methods
The Kaplan-Meier survivorship method12 was used *Pulmonary congestionroentgenographic evidence of interstitial or alveolar edema; congestive heart failuresignificant pulmonary rales and/or pitting edema.
to compute the cumulative percentage of death for specific groups of patients. This method takes into account varying duration of follow-up after baseline examination. In the present study the mean follow-up was 36 months (range 1-60 months). Comparison of the mortality curves among patient groups was carried out using the Wilcoxon-Breslow method.'3 The technique uses a chi-square approximation to the test statistic adjusting for differences in follow-up duration among the groups.
To evaluate whether complex VEBs were an independent predictor of mortality, several generalized Wilcoxon-Breslow'3 analyses were carried out controlling for selected clinical variables taken one at a time by the Mantel-Haenszel technique.'4 This approach permitted adjustment for the single covariates and for differences in follow-up duration. Conversely, the role of selected clinical variables on mortality was evaluated while controlling for complex VEBs. Results
Description of the Population
The clinical characteristics of the population (n = 940), the cardiac death group (n = 115), and the sudden (n = 55) and nonsudden (n = 43) deaths are presented in table 1. The univariate clinical characteristics of the sudden and nonsudden cardiac deaths were similar except for a significantly (p < 0.01) larger percentage of early demise (< 2 months) and a smaller percentage of out-of-hospital deaths in the nonsudden compared with the sudden death group.
VEBs and Mortality
The cumulative cardiac mortality after the predischarge Holter recording for patients with no VEBs, simple VEBs, and complex VEBs is presented in figure  1 . Patients with complex VEBs have the greatest early and total mortality, and patients with simple VEBs have a mortality rate intermediate between those with complex and those with no VEBs. This graphical ordering is supported by the Wilcoxon-Breslow tests of significance ( fig. 1 ). Within the simple and complex VEB categories, high VEB frequency (> 20/hour) was not associated with increased mortality when compared with patients with low frequency (< 20/hour).
The relationships of predischarge VEB status to subsequent sudden and nonsudden cardiac death are shown in figure 2. Complex VEBs are associated with an increased likelihood of both sudden and nonsudden death. Although the graphs suggest some ordering, differences between the mortality rates for those with simple or no VEBs were not statistically significant for either sudden or nonsudden death ( fig. 2 ).
VEBs and Risk Stratification in Relation to Mortality
Previously we reported that patients having an AMI, LVD in the CCU, and one or more VEBs on the predischarge Holter recording were at a signifi- See Methods section for definition of variables.
*Social class IV and V: derived from the Hollingsheadl" five-level occupational and educational class rank,
where levels IV and V are the lowest two levels of social class.
tMedication: Medication usage before discharge for the total population and in the week before death. tp < 0.01 sudden vs nonsudden cardiac death.
Abbreviations: NYHA class = New York Heart Association functional classification; VEB = ventricular ectopic beat. cantly greater risk of cardiac mortality than the rest of the population.'6 17 The identification of this high-risk subset together with the above results stimulated us to investigate the relative effect of no, simple and complex VEBs on cardiac death in patients with and without the AMI-LVD combination. The breakdown of the 253 patients who had both AMI and LVD into subgroups with no, simple, and complex VEBs is presented in table 2. The cumulative mortality for these high-risk patients sub- divided by the complexity of VEBs is presented in figure 3 . There is an ordering among the three VEB groups, with complex VEBs associated with the greatest risk for early and total mortality in this highrisk group (fig. 3 ). The relevant Wilcoxon-Breslow tests of significance for curve comparisons are presented in figure 3 .
Prognostic Independence of Complex VEBs
Since complex VEBs were associated with a significantly increased sudden and nonsudden cardiac death rate, the prognostic independence of complex VEBs in relation to overall cardiac death was investigated. Ten clinical variables were selected to evaluate the interaction between complex VEBs and the presence of these variables taken one at a time on cardiac mortality. The clinical variables were chosen on the basis of their previously demonstrated association with complex VEBs, their relationship with cardiac death in previous reported studies, or on the basis of the investigators' clinical judgment. A Mantel-Haenszel-type generalization"4 of the Wilcoxon-Breslow technique'3 permitted: 1) an evaluation of the importance of complex VEBs in cardiac death when controlling for the selected clinical variables, and 2) an evaluation of the importance of the selected clinical variables in cardiac death when controlling for complex VEBs.
These analyses are presented in table 3 as chi-square and p values. The first of two columns of table 3 give the significance of the association between complex VEBs and cardiac death when the selected clinical variables were controlled one at a time. The and these findings indicate the independent role of complex VEBs in mortality after myocardial infarction. The last two columns in table 3 give the significance of the association between each selected clinical variable and cardiac death when controlling for complex VEBs. Five factors are significant (p < 0.01) independent of complex VEBs: 1) advanced NYHA functional class before entry; 2) a history of angina pectoris before entry; 3) a previous myocardial infarction before the index event; 4) AMI; and 5) LVD in the CCU.
Discussion
This study substantiates the association between complex VEBs and an increased overall cardiac death rate in the posthospital phase of myocardial infarction. Complex VEBs appear equally effective in identifying postcoronary patients who subsequently die suddenly or nonsuddenly as we have defined. These findings are similar to the results of the Coronary Drug Project, in which a significant association was found between VEBs recorded on a 12-lead ECG and both sudden and nonsudden cardiac death in a 3-year period after myocardial infarction. 7 In the recent Ruberman et al.8 study from the Health Insurance Plan (HIP) of New York City, complex VEBs were associated with an increased postinfarction mortality, especially for sudden cardiac death. The HIP program is analogous to our study in prospective design, size, VEB categorization, and purpose, but several important differences exist that may explain the different results. The HIP program used: 1) an unrestricted age, necessitating complex ageadjustment techniques in the data analysis; 2) an allmale population; 3) only a 1-hour sedentary Holter recording; 4) a significant hiatus between the AMI and the Holter recordinga majority of the patients were recorded 3 months or more after the infarction; 5) a definition of sudden death analogous to "instantaneous" as defined by Friedman et al.;'8 and 6) mortality end points that did not include nonsudden cardiac death. A recent analysis of the deaths in our Rochester study revealed the preponderance of nonsudden death in the first 2 months after hospital discharge with a progressively increasing proportion of sudden deaths occurring 3 months or later after infarction. The HIP program, by obtaining the Holter recordings in the 3-12 month posthospital interval, did not include the patients who died in the early posthospital period, the interval when nonsudden death predominates. The HIP investigators focused on the association between complex VEBs and sudden death, Prior studies have demonstrated considerable variability in the VEB frequency and complexity over 72-hour recording periods19 and during intervals extending over days to months.20' 21 Therefore, it is not surprising that complex VEBs recorded before hospital discharge lack specificity regarding mode of death that occurs months to years later. The findings of the present study support the speculative comments of Lovell, who believed that VEBs were likely to be associated with all modes of dying and not just sudden death. 22 In the Pooling Project involving the Albany and Framingham populations, no single risk factor or combination of factors separated persons uniquely destined to die suddenly from those who would experience a more protracted death. 23 Doyle and his associates conjectured that sudden death from coronary disease is related to the exact nature of the pathologic changes in the heart,23 and this assumption is supported by the recent report of Rissanen et al. 24 They found that the severity of obstructive changes in the coronary arteries was no different in patients who died suddenly than in those who died after a period of symptoms, whether under or over 2 hours.
When 10 clinical variables were controlled one at a time, complex VEBs were shown to make an independent contribution to the risk of cardiac death. In each case in which the specific variable was controlled, the association between complex VEBs and cardiac death was highly significant, with chi-square values from 16-30. Although complex VEBs have prognostic power by themselves, it is reasonable to assume that complex VEBs are only one of the many factors associated with an increased likelihood of cardiac death. Certainly, the extent of the coronary disease process, the degree of myocardial scarring, and the functional state of global cardiac performance must be as important, if not more important, than complex VEBs as contributing mechanisms to cardiac death. Numerous clinical, epidemiologic and pathologic studies support this hypothesis. [25] [26] [27] If so, chronic therapy with antiarrhythmic agents might not be as effective in reducing cardiac mortality including sudden death in the posthospital phase of myocardial infarction as once thought.
